Moderna to Use New mRNA Technology to Develop Coronavirus Vaccine
Story Highlights In light of the coronavirus outbreak, three research teams have been awarded grants by the Coalition for Epidemic Preparedness Innovations to develop a vaccine for the novel coronavirus. In a public-private partnership with NIH, Moderna, Inc. is using an experimental mRNA technology to develop a vaccine. Johnson & Johnson and other drug companies […]
Injecting TB Vaccines Into the Veins vs Reducing Poverty
The journal Nature recently reported that tuberculosis (TB) vaccine developers discovered TB vaccine is much more effective if it is injected directly into the veins of monkeys rather than into the skin. Researchers at the University of Pittsburgh School of Medicine and the National Institute of Allergy and Infectious Diseases (NIAID) found that administering BCG—the […]
Executive Order Creates Influenza Vaccine Task Force to Promote “National Security and Public Health”
On Sept. 19, 2019, President Donald Trump signed an Executive Order, “Modernizing Influenza Vaccines in the United State to Promote National Security and Public Health.” Describing mass use of influenza vaccines “to combat seasonal flu” and influenza pandemics as “strengthening our Nation’s public health and security,” he announced the establishment of a National Influenza Vaccine […]
Viral Link to AFM Sought in University of Alabama Study
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded the University of Alabama at Birmingham (UAB) a five-year $10 million contract to study the polio-like condition known as acute flaccid myelitis (AFM), also sometimes referred to as acute flaccid paralysis (AFP).1 2 According to the National Institutes of Health (NIH), “As part […]
NIH and Johnson & Johnson to Begin HIV Vaccine Trials on Humans
Story Highlights NIH, in collaboration with Johnson & Johnson, will begin HIV vaccine efficacy trials on humans in August 2019 in the U.S. Another HIV vaccine candidate, using a live attenuated herpes cytomegalovirus (CMV), is also nearing clinical trials in humans. There are serious safety concerns regarding live attenuated vaccines and numerous cases reported in […]
